Aug. 12, 2021
CEO Update: Aviptadil & patents for VIP
Every day at NRx we get a variety of questions about our science, business, and other aspects of our work. This CEO Update concerns aviptadil and questions about patents for this peptide. Q: What’s the difference between aviptadil and VIP?A: VIP stands for vasoactive intestinal peptide. It is made in specialized cells like insulin. Aviptadil is […]